Alert: Levonorgestrel ECP gets FDA approval
As Contraceptive Technology Update went to press, the Women’s Capital Corporation of Seattle was preparing its new levonorgestrel-only emergency contraceptive pill (ECP), Plan B, for U.S. shipment. Interest in a dedicated progestin-only product has grown since a 1998 international study showed that the levonorgestrel pills are more effective and have fewer side effects than the current regimen using combined oral contraceptives for emergency contraception.
For more information on Plan B, as well as other emergency contraception news, turn to the story on p. 108.
Article Limit Reached
You have reached your article limit for the month. Subscribe now to access this article plus other member-only content.
- Award-winning Medical Content
- Latest Advances & Development in Medicine
- Unbiased Content